— Know what they know.
Not Investment Advice

NVRO NYSE

Nevro Corp.
1W: -0.2% 1M: +1.9% 3M: +57.0% 1Y: -56.2% 3Y: -91.3% 5Y: -93.5%
$5.84
Last traded 2025-04-02 — delisted
NYSE · Healthcare · Medical - Devices · $224.1M mcap · 34M float · 3.80% daily turnover · Short 35% of daily vol

Revenue Segmentation

By Product / Service

By Geography

Revenue by Segment (5-Year Trend)

Income Trends

Revenue
$409M -3.9% ▼
5Y CAGR: +0.9%
Gross Profit
$270M -7.1% ▼
5Y CAGR: +0.1%
Operating Income
-$126M -27.1% ▼
Net Income
-$113M -23.0% ▼
EPS (Diluted)
$-3.06 -19.5% ▼
EBITDA
-$125M -61.2% ▼

Profit Margins

Year-over-Year Growth

View Full Income Statement
Line ItemFY2020FY2021FY2022FY2023FY2024
Revenue$362M$387M$406M$425M$409M
YoY Growth-7.2%+6.9%+5.0%+4.6%-3.9%
Cost of Revenue$112M$121M$130M$135M$139M
Gross Profit$250M$266M$276M$290M$270M
Gross Margin69.0%68.8%68.0%68.2%66.0%
R&D Expenses$46M$48M$53M$54M$52M
SG&A Expenses$267M$309M$322M$335M$310M
Operating Expenses$313M$357M$375M$389M$396M
Operating Income-$63M-$91M-$99M-$99M-$126M
Operating Margin-17.4%-23.5%-24.3%-23.4%-30.9%
Interest Expense$22M$20M$6M$8M$27M
Income Before Tax-$82M-$131M$4M-$98M-$112M
Tax Expense$868K$534K$1M-$6M$1M
Net Income-$83M-$131M$3M-$92M-$113M
Net Margin-22.9%-34.0%0.7%-21.7%-27.8%
EPS (Diluted)$-2.47$-3.77$0.08$-2.56$-3.06
EBITDA-$52M-$102M$21M-$78M-$125M
Shares Outstanding34M35M36M36M37M

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms